332
Participants
Start Date
October 4, 2023
Primary Completion Date
May 31, 2025
Study Completion Date
May 31, 2025
Diagnostic Test: Rapid Intestinal anti-TG2 Assay
"Evaluation of the reliability of the Rapid Intestinal anti-TG2 Assay for revealing anti-TG2 antibodies in duodenal biopsy specimens of patients suffering from CD, especially potential CD in which the diagnosis may be challenging.~Intestinal anti-TG2 will be investigated also in patients suffering from other non-CD related gastrointestinal disorders. Sensitivity, specificity and likelihood ratios of the Rapid Intestinal anti-TG2 assay will be calculated and compared to the reference standard (serology + histopathology) of CD diagnosis."
Diagnostic Test: Rapid Intestinal anti-TG2 Assay
"Evaluation of the reliability of the Rapid Intestinal anti-TG2 Assay for revealing anti-TG2 antibodies in duodenal biopsy specimens of patients suffering from CD, especially potential CD in which the diagnosis may be challenging.~Intestinal anti-TG2 will be investigated also in patients suffering from other non-CD related gastrointestinal disorders. Sensitivity, specificity and likelihood ratios of the Rapid Intestinal anti-TG2 assay will be calculated and compared to the reference standard (serology + histopathology) of CD diagnosis."
RECRUITING
"Institute for Maternal and Child Health - IRCCS Burlo Garofolo", Trieste
RECRUITING
Azienda Ospedaliera Universitaria Federico II, Napoli
ACTIVE_NOT_RECRUITING
Consorzio per Valutazioni Biologiche e Faramacologiche, Pavia
RECRUITING
Azienda ULSS2 Marca Trevigiana, Treviso
IRCCS Burlo Garofolo
OTHER